New White Paper - Proactive Pharmacovigilance: A New Model for the 21st Century

21st century technologies will create significant opportunities and challenges for all health care stakeholders. Pharmacovigilance too is in transition, with new sources of medical information and methods for its analysis that will transform today's largely reactive system into proactive benefit-risk management for all medication users.

Key topics:

• Why do we need a new PV model?
• What might effective PV look like in 2038?
• What are some new data sources?
• How can I improve clinical decision making?
• How do we achieve broad accessibility of appropriate information?
• What are the cost-benefit considerations?

Download now

provided by Sciformix

Factoring the "what ifs" into supply forecasting: Why building a durable supply chain around a protocol is critical

Answering the "What IF" Questions

Download this free white paper now.

Effective supply planning requires decision making that strikes a balance between what's known and unknown, risk and budget, the needs of the trial and those of patients. The ultimate goal is ensuring that the right patients receive the right drugs at the right time. Otherwise, everyone sponsors, investigators, patients and society at large stands to lose. This white paper goes into great detail on the topic, including "what-if" scenarios, real-life disasters, and 15 industry references to additional information.

Provided by: Fisher Clinical Services